Who has invested in NGM Bio Holdings?

The Column Group, KdT Ventures are named among the investors backing NGM Bio Holdings.

NGM Bio Holdings Funding: $257M Raised, Series A (2024)

NGM Bio Holdings funding overview

NGM Bio Holdings is based in South San Francisco, CA. NGM Bio Holdings has raised $257M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in July 2024. The round record for NGM Bio Holdings runs through 2024; nothing later has been disclosed. Investors on record include The Column Group, KdT Ventures. 2 distinct backers are named across the disclosed rounds.

NGM Bio Holdings at a glance

Total raised: $257M
Latest round: Series A
Latest round date: July 2024
Headquarters: South San Francisco, CA
Notable investors: The Column Group, KdT Ventures

Frequently asked about NGM Bio Holdings funding

How much has NGM Bio Holdings raised?: NGM Bio Holdings has raised $257M in total disclosed funding across the rounds on record.
Who has invested in NGM Bio Holdings?: The Column Group, KdT Ventures are named among the investors backing NGM Bio Holdings.
What was the latest NGM Bio Holdings funding round?: The most recent disclosed round is a Series A, announced in July 2024.
Where is NGM Bio Holdings based?: NGM Bio Holdings is based in South San Francisco, CA.
When did NGM Bio Holdings last raise?: The last disclosed NGM Bio Holdings round closed in July 2024 at Series A.

We update the NGM Bio Holdings record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South San Francisco and their backers are listed below.

NGM Bio Holdings Funding: $257M Raised, Series A (2024)

NGM Bio Holdings funding overview

NGM Bio Holdings at a glance

Frequently asked about NGM Bio Holdings funding

Companies related to NGM Bio Holdings (35)

Browse related funding lists (4)